A lower preprocedural adiponectin level is strongly associated with increased insulin resistance, as reflected by higher HOMA-IR scores, and an increased risk of restenosis and adverse ischemic events, suggesting that hypoadiponectinemia identifies a metabolically vulnerable phenotype even in the absence of diagnosed diabetes [57]. Here, ADIPOQ is linked to adiponectin deficiency.